BioCentury | Oct 20, 2003
Finance

Ebb & Flow

...by Perseus-Soros BioPharmaceutical Fund and Bay City Capital, which were joined by Granite Global Ventures; Venture TDF...
BioCentury | Oct 28, 2002
Finance

Ebb & Flow

...intravitreal delivery of dexamethasone, to treat persistent macular edema. Other investors included Granite Global Ventures; Venture TDF...
BioCentury | Oct 22, 2002
Financial News

Oculex raises $50 million

...led by Perseus-Soros BioPharmaceutical Fund and Bay City Capital. Other investors included Granite Global Ventures; Venture TDF...
Items per page:
1 - 3 of 3
BioCentury | Oct 20, 2003
Finance

Ebb & Flow

...by Perseus-Soros BioPharmaceutical Fund and Bay City Capital, which were joined by Granite Global Ventures; Venture TDF...
BioCentury | Oct 28, 2002
Finance

Ebb & Flow

...intravitreal delivery of dexamethasone, to treat persistent macular edema. Other investors included Granite Global Ventures; Venture TDF...
BioCentury | Oct 22, 2002
Financial News

Oculex raises $50 million

...led by Perseus-Soros BioPharmaceutical Fund and Bay City Capital. Other investors included Granite Global Ventures; Venture TDF...
Items per page:
1 - 3 of 3